News

Deal Announcements

Aeolus Pharma Nets More Venture Capital Investment

Friday, April 20, 2012 5:57:00 AM PDT | VentureDeal Staff
Mission Viejo, California  --  Aeolus Pharmaceuticals has reported it has received $690,000 in new investment.

Aeolus is developing a new class of catalytic antioxidant compounds for diseases and disorders of the central nervous system and other systems of the human body.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1